HIV PrEP Treatment Increased Five-Fold From 2014 to 2017: Report
A CDC study found that use of Truvada for HIV prevention increased 500% from 2014 to 2017.…
«
»
A CDC study found that use of Truvada for HIV prevention increased 500% from 2014 to 2017.…
U.S. lawmakers are wondering whether Gilead’s recent donation of millions of bottles of Truvada came with a backdoor deal for the government to drop patent claims on the drug.…
A new class action lawsuit by an investor group accuses Gilead and other drug makers of antitrust law violations for preventing generic versions of HIV drugs.…
Lawmakers questioned Gilead’s CEO on why its HIV drugs cost so much in the U.S., amid claims of price-fixing.…
Gilead and other drug manufacturers face a class action lawsuit claiming they conspired to keep generic HIV drugs off the market and to artificially inflate HIV drug prices.…
A new study finds that the use of HIV antiviral cocktail drugs cuts transmission to zero, even as concerns over their toxicity grows.…
A new study warns that Truvada, Stribild and similar HIV drugs may be causing neurocognitive degeneration in HIV-positive patients.…
Plaintiffs who have filed HIV drug lawsuits against Gilead say that the company intentionally sold highly toxic drugs, knowing it would release a safer variant a few years later to extend its profits and to take advantage of patent protections.…
The pharmaceutical industry is expanding its advertising spending at a rate faster than any other industry, at a time when some health experts say direct-to-consumer ads for prescription drugs should be banned.…
Gilead is warning that its hepatitis C drugs, Harvoni and Sovaldi may increase the risk of heart rhythm problems and death in patients also taking the heart drug amiodarone.…